Glenmark Therapeutics launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC), a generic version of Pataday Twice Daily Relief, which provides eye allergy itch relief. 

"We are excited to announce the launch of Olopatadine Ophthalmic Solution USP, 0.1%, addressing the growing demand for a new supplier in this category,” said Fabio Moreno, head, OTC sales and marketing, Glenmark Pharmaceuticals, in a press release. “This addition highlights our commitment to meeting market needs and providing high-quality over-the-counter solutions for our customers."